Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


Taub Rebecca Create: Alert

All | News | Filings
Date FiledTypeDescription
01/18/2023 4 Taub Rebecca (Pres., R&D, and CMO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.
Txns: Granted 20,001 shares @ $0
08/01/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
02/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/05/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/17/2019 SC 13D/A Taub Rebecca reports a 8.2% stake in Madrigal Pharmaceuticals, Inc.
07/11/2019 4 Taub Rebecca (President of R&D) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.
Txns: Granted 8,000 options to buy @ $101.3, valued at $810.4k
03/11/2019 4 Taub Rebecca (Chief Medical Officer, EVP R&D) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.
Txns: Granted 38,000 options to buy @ $127.96, valued at $4.9M
06/12/2018 4 Taub Rebecca (Chief Medical Officer, EVP R&D) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.
Txns: Sold 73,526 shares @ $287.46, valued at $21.1M
03/05/2018 4 Taub Rebecca (Chief Medical Officer, EVP R&D) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.
Txns: Granted 38,000 options to buy @ $124.45, valued at $4.7M
03/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
08/23/2016 4/A Taub Rebecca (Chief Medical Officer, EVP R&D) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.
Txns: Granted 30,626 shares @ $0
Granted 153,128 options to buy @ $9.45, valued at $1.4M
08/01/2016 SC 13D Taub Rebecca reports a 10.4% stake in Madrigal Pharmaceuticals, Inc.
07/26/2016 4 Taub Rebecca (Chief Medical Officer, EVP R&D) has filed a Form 4 on SYNTA PHARMACEUTICALS CORP
Txns: Granted 729,066 shares @ $0
Granted 404,132 shares @ $0
Granted 28,740 shares @ $0
Granted 143,557 options to buy @ $9.45, valued at $1.4M
07/26/2016 3 Taub Rebecca (Chief Medical Officer, EVP R&D) has filed a Form 3 on SYNTA PHARMACEUTICALS CORP
12/19/2008 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy